Headaches are fairly common, with nearly one in six people experiencing one on any given day. Your likelihood of experiencing a headache may be more common if you’re taking a glucagon-like peptide-1 (GLP-1) medication for type 2 diabetes or weight loss. Some GLP-1s may be more likely to cause headaches than others, including semaglutide (the active ingredient in Ozempic, Wegovy, and Rybelsus) and liraglutide (the active ingredient in Victoza and Saxenda).
Learn about the link between GLP-1s and headaches and what you can do to prevent and relieve headaches.
GLP-1 Headache Causes And What To Do About Them
Some GLP-1s list headache as a common side effect, especially when starting the medication or increasing your dose. GLP-1 headaches can also occur if you experience dehydration, low blood sugar, or one of the gastrointestinal side effects common with these medications.
Beginning and Increasing Doses
GLP-1s increase blood flow in the brain and may also lower blood pressure. This may cause your peripheral nerves to stretch while also expanding blood vessels in the brain, which can trigger a headache. When you first start the medication, your body may experience this effect for the first time. When you increase your dosage, the headaches may come back as your body adjusts to the increased effects of the higher dose. Either way, you might experience a headache as a result.
You’re also more likely to experience more intense gastrointestinal side effects whenever you begin a GLP-1 or increase your dose. Some of these side effects — such as nausea, vomiting, and diarrhea — can cause dehydration, which can also contribute to headache.
What You Can Do
Here’s what you can do to prevent headaches due to starting or changing your GLP-1 dose.
- Hydrate, hydrate, hydrate. Dehydration is a common cause of headache. One of the best things you can do to avoid headache during GLP-1 treatment is to stay hydrated by drinking plenty of water and eating water-rich foods, like soup. Staying hydrated can also help prevent dehydration from other GLP-1 side effects like nausea, vomiting, and diarrhea.
- Don’t skip meals. You might experience low appetite or an upset stomach from your GLP-1, but try to eat regularly — even if it’s just something small. Having a small snack or meal can help you avoid low blood sugar and vomiting, either of which can trigger a headache.
- Wait it out. Gastrointestinal side effects like nausea, vomiting, diarrhea are more common during the first few months of treatment, and tend to go away on their own once your body adjusts to the medication.
Looking for GLP-1 treatments or headache relief?
Dehydration and Eating Less
Dehydration is a leading trigger of headache and migraine. GLP-1s increase your risk of dehydration, especially in the beginning when you’re experiencing a newly reduced appetite and side effects like nausea, vomiting, and diarrhea.
When you’re less hungry, you may end up drinking less than you normally would. You might also lose additional fluids from vomiting or diarrhea.
What You Can Do
Here’s what you can do to help prevent headaches due to dehydration.
- Hydrate, hydrate, hydrate. This one bears repeating. Staying hydrated is the best way to prevent dehydration. Keep a water bottle nearby and sip on it throughout the day.
- Eat water-rich foods. Foods like soup, low-fat yogurt, and gelatin can help you meet your nutritional needs while also preventing dehydration.
- Eat more often. You may be less hungry, but it’s still important to eat. You might feel better if you eat smaller meals more frequently during the day, as opposed to just a few large meals.
Low Blood Sugar
Headache can be a warning sign of low blood sugar (hypoglycemia), which may be more likely to occur when you’re taking a GLP-1 in combination with insulin or certain diabetes medications. This is of particular concern for people who take GLP-1s like Ozempic (semaglutide) or Mounjaro (tirzepatide) to manage their type 2 diabetes.
When taken for type 2 diabetes, GLP-1s work by lowering blood sugar levels. Sometimes, however, blood sugar levels may drop too low, which can result in headache and other warning signs like:
- Double or blurry vision
- Fast heartbeat
- Irritability or restlessness
- Hunger
- Sweating
- Shaking
- Seizures
- Skin tingling or numbness
- Weakness
Low blood sugar can also occur if you are taking a GLP-1 like Zepbound (tirzepatide) for weight loss.
What You Can Do
Here’s what you can do to help prevent headaches due to low blood sugar.
- Monitor your blood sugar levels. If you’re using a GLP-1 for diabetes, continue to regularly monitor your blood sugar levels as directed by your provider.
- Don’t go too long without eating. Your body needs glucose from food to keep your blood sugar levels up. Try to eat on a regular schedule.
- Keep a source of quick sugar on hand. If your blood sugar gets low, you can quickly raise it by having some juice or taking a glucose tablet. Ask your healthcare provider what fast-acting sugar sources they recommend if you experience low blood sugar.
Nausea, Vomiting, and Diarrhea
The most common side effects of GLP-1s are gastrointestinal, namely nausea, vomiting, and diarrhea. These side effects cause you to lose fluids, which can put you at risk for another side effect: headaches.
These side effects are worst during the first few weeks to months of treatment with GLP-1s. As your body adjusts to the medication, the GI side effects tend to lessen.
What You Can Do
Here’s what you can do to help prevent headaches due to nausea, vomiting, and diarrhea.
- Avoid dehydration. Staying well-hydrated may help prevent GLP-1 headaches that occur from dehydration. Health experts recommend sipping on cold, clear liquids like water.
- Stop eating once you feel full. It can take time to adjust to your new, lower appetite when you start GLP-1s. Try eating smaller meals throughout the day, and stop eating once you feel full. These mindful eating practices can help you avoid feeling overly full, which can then lead to nausea, possibly vomiting, and dehydration.
- Eat bland foods. Bland foods can be easier on the stomach. Opt for low-fat options like crackers and apples, or water-rich soup or yogurt.
Compounded GLP-1 Medications
A compounded GLP-1 is a custom version of a GLP-1 medication produced by a compounding pharmacy rather than the drug manufacturer. In compounded formulations, GLP-1s may be combined with other ingredients that aren’t included in the FDA-approved medication, such as vitamin B12. It may also contain a different active ingredient altogether, such as semaglutide salts vs. the base form of semaglutide used in Wegovy and Ozempic.
Compounded medications are not FDA-approved. In the case of compounded GLP-1s, the FDA has issued warnings about them due to the increased risk of dosing errors and side effects.
Because compounded GLP-1s often come in multi-dose vials, people taking them need to draw their own dose, which can lead to an accidental overdose. Headache, extreme nausea or abdominal pain, fainting, and other serious side effects may occur. Since facing FDA scrutiny, compounded GLP-1s are no longer as common but may still be available.
What You Can Do
Here’s what you can do to prevent headaches due to compounded GLP-1 medications.
- Make sure to draw an accurate dose. Follow the instructions provided with the compounded GLP-1 to ensure you are measuring the correct dose each time.
- Switch to a non-compounded formula. If you’re concerned that your headache is caused by the compounded GLP-1 or what it is compounded with, talk to your healthcare provider about switching to an FDA-approved, non-compounded GLP-1 such as Ozempic or Mounjaro.
Headache Risks By GLP-1 Medication
| Brand Name | Medication and Drug Type | Headache |
|---|---|---|
| Byetta | Exenatide, GLP-1 | Affects 9% of users |
| Foundayo | Orforglipron, GLP-1 | Affects 8%–9% of users |
| Mounjaro | Tirzepatide, GIP/GLP-1 | Not listed as common side effect |
| Ozempic | Semaglutide, GLP-1 | Not listed as common side effect |
| Saxenda | Liraglutide, GLP-1 | Affects 14% of users |
| Trulicity | Dulaglutide, GLP-1 | Not listed as common side effect |
| Victoza | Liraglutide, GLP-1 | Affects 10–11% of users |
| Wegovy | Semaglutide, GLP-1 | Affects 8%–14% of users |
| Zepbound | Tirzepatide, GIP/GLP-1 | Not listed as common side effect |
The table above is based on the most common side effects reported in clinical trials, but individual experiences of side effects may differ.
Different GLP-1s may have different risks of headache based on how much of the active ingredient they contain. For example, headache is not listed as a common side effect of Ozempic, which contains semaglutide. However, Wegovy, which also contains semaglutide, lists headache as a common side effect.
How To Beat a GLP-1 Headache
Follow these proven tips for preventing (and treating) a GLP-1 headache.
- Avoid getting dehydrated by drinking plenty of water and clear fluids.
- Eat smaller portions, more often vs. larger portions, less often.
- Stop eating once you feel full.
- Monitor your blood sugar levels as directed by your doctor.
- Place a cool compress on your head, and lie down in a quiet place to rest.
- Take OTC headache medications, such as ibuprofen or acetaminophen. Check with your doctor first, if you have any medical conditions or take other medications.
What Not To Do With a GLP-1 Headache
If you experience a GLP-1 headache, here’s what not to do.
- Don’t change your dose or stop taking your GLP-1 without talking to your healthcare provider.
- Don’t take painkillers too often (medication overuse can lead to rebound headaches). Talk to your healthcare provider if you get headaches frequently.
- Don’t go too long without eating something.
- Don’t overexert yourself.
- Don’t eat foods that make you feel nauseous.
If you’re experiencing GLP-1 headaches often, it’s a good idea to talk to your healthcare provider. They can recommend what you should cut from — or add to — your regimen.
Medication Access Made Easy
Getting your GLP-1 refill or pain relief medication shouldn’t feel like you’re jumping through hoops. With digital pharmacy platforms like TelyRx, you can order your medication online safely and securely.
Every medication request sent through TelyRx is reviewed by a licensed healthcare provider. They’ll take a look at your medical history to ensure the medication is safe for you to take before approving your request. Once it’s approved, the medication is sent directly to you.
If this is your first time using an online pharmacy, it’s a good idea to check that one you’re considering is legitimate. The best telehealth platforms have:
- LegitScript certification
- FDA-approved medications
- Trusted sourcing from U.S.-based wholesalers
- Proper pharmacy licensure
- Transparent pricing
By the way, TelyRx checks off all of these green flags. Explore our catalog of FDA-approved medications for diabetes and weight loss, and see how our prices compare to other online pharmacies.
Your Next Steps
Headaches can be a bothersome side effect of GLP-1s, but it is possible to prevent and treat them. Doing your best to stay hydrated, get enough food, eat smaller, more frequent meals, and manage other GI side effects can go a long way in preventing GLP-1 headaches.
If your GLP-1 headaches get worse or continue to bother you, reach out to your healthcare provider. They can recommend a personalized care plan for limiting your headaches, whether that includes taking pain relief medications as needed, starting a preventive medication, or switching to another GLP-1.
Research & References
Arca, K. N., & Singh, R. B. H. (2021). Dehydration and headache. Current Pain and Headache Reports, 25(8), 56. https://doi.org/10.1007/s11916-021-00966-z
Baraness, L., & Baker, A. M. (2023, July 26). Acute headache. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK554510/
DailyMed. (2026). Label: FOUNDAYO- orforglipron tablet, film coated. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62
DailyMed. (2026). Label: OZEMPIC- oral semaglutide tablet RYBELSUS- oral semaglutide tablet. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98
DailyMed. (2026). Label: OZEMPIC- semaglutide injection, solution. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
DailyMed. (2026). Label: WEGOVY- semaglutide injection, solution WEGOVY- semaglutide tablet. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
Filippatos, T. D., Panagiotopoulou, T. V., & Elisaf, M. S. (2014). Adverse effects of GLP-1 receptor agonists. The Review of Diabetic Studies, 11(3–4), 202–230. https://doi.org/10.1900/rds.2014.11.202
Gao, L., Yu, S., Cipriani, A., Wu, S., Huang, Y., Zhang, Z., Yang, J., Sun, Y., Yang, Z., Chai, S., Zhang, Y., Ji, L., Zhan, S., & Sun, F. (2019). Neurological Manifestation of Incretin-Based Therapies in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Aging and Disease, 10(6), 1311. https://doi.org/10.14336/ad.2019.0303
Gorgojo-Martínez, J. J., Mezquita-Raya, P., Carretero-Gómez, J., Castro, A., Cebrián-Cuenca, A., De Torres-Sánchez, A., García-De-Lucas, M. D., Núñez, J., Obaya, J. C., Soler, M. J., Górriz, J. L., & Rubio-Herrera, M. Á. (2022). Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. Journal of Clinical Medicine, 12(1), 145. https://doi.org/10.3390/jcm12010145
Khorsha, F., Mirzababaei, A., Togha, M., & Mirzaei, K. (2020). Association of drinking water and migraine headache severity. Journal of Clinical Neuroscience, 77, 81–84. https://doi.org/10.1016/j.jocn.2020.05.034
Lu, W., Wang, S., Tang, H., Yuan, T., Zuo, W., & Liu, Y. (2025). Neuropsychiatric adverse events associated with Glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database. European Psychiatry, 68(1), e20. https://doi.org/10.1192/j.eurpsy.2024.1803
MedlinePlus. (2025). Headache. https://medlineplus.gov/ency/article/003024.htm
MedlinePlus. (2026). Low blood sugar. https://medlineplus.gov/ency/article/000386.htm
MedlinePlus. (2026). Tirzepatide injection. https://medlineplus.gov/druginfo/meds/a622044.html
Stovner, L. J., Hagen, K., Linde, M., & Steiner, T. J. (2022). The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. The Journal of Headache and Pain, 23(1), 34. https://doi.org/10.1186/s10194-022-01402-2
U.S. Food and Drug Administration (FDA). (2024). FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
U.S. Food and Drug Administration (FDA). (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss






